CompletedNot Applicable

Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE).

Pakistan60 participantsStarted 2019-10-10

Plain-language summary

Evaluation of antiphospholipid antibodies (aPL) profile in Systemic lupus erythematosus (SLE) patients with obstetric and thrombotic complications. Blood sample of the patients were taken for Anti-beta-2-glycoprotein 1(anti-b2GPI), anticardiolipin (aCL) and will be analyzed on Alegria based on ELISA.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Diagnosed patients of SLE presenting with thrombosis \& pregnancy complication were studied \- Exclusion Criteria: * Patients of SLE without thrombosis

What they're measuring

aPLS antibodies of any type and number lead to cumulative obstetric and thrombotic complication in patients of SLE.

Timeframe: 2 years

B2 GPI is more prevalent in patients with antiphospholipid syndrome

Timeframe: 2 years

Trial details

NCT IDNCT04963881

SponsorFatima Memorial Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-01-01

View on ClinicalTrials.gov More Anti-phospholipid Antibobodies in Patients of SLE Presenting With Thrombosis or Pregnancy Complications trials